Comparative analysis of clinical and biological characteristics of COVID-19 patients: A retrospective cohort study

被引:2
|
作者
Yahyaoui, Abir [1 ,2 ]
Amrani, Abdessamad [1 ,2 ]
Idrissi, Amjad [1 ,2 ]
Belmahi, Sabrina [1 ,2 ]
Nassiri, Oumaima [1 ,2 ]
Mouhoub, Boutaina [1 ,2 ]
Sebbar, Elhoucine [1 ,2 ]
Hamaz, Siham [1 ,2 ,3 ]
Choukri, Mohammed [1 ,2 ]
机构
[1] Mohammed VI Univ Hosp, Cent Lab, Oujda, Morocco
[2] Mohammed First Univ, Fac Med & Pharm Oujda, Oujda, Morocco
[3] Mohammed VI Univ Hosp, Infect Dis Immunohematol & Cellular Therapy Lab, Oujda, Morocco
关键词
Biomarkers; COVID-19; Risk factor; SARS-CoV-2; Severe group; RESPIRATORY SYNDROME CORONAVIRUS; DISEASE;
D O I
10.1016/j.cegh.2022.101184
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Coronavirus disease (COVID-19), caused by a betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly evolved into a pandemic since it was first reported in December 2019. thus, SARS-CoV-2 has become a major global public health issue. Objective: The objective of this work is to compare demographics, comorbidities, clinical symptoms, biology and imaging findings between severe and non-severe COVID-19 patients and to identify clinical and biological risk factors and biomarkers for the development of severe COVID-19 as well as predictive thresholds for severity in order to best rationalize management and decrease the morbidity and mortality caused by this condition. Patients and methods: This is a single-center retrospective study, from June 25 to December 31, 2021, on 521 patients at the level of the unit COVID-19 of the central laboratory of the Mohammed VI University Hospital Center Oujda, then classified into two groups according to the severity of the disease. Results: Out of a total of 521 patients, a severe group including 336 cases (64.5%) and a non-severe group with 185 cases (35.5%). Hypertension, diabetes and obesity were noted in the majority of patients. Severe COVID-19 cases had higher C-reactive protein, procalcitonin, D-dimer, ferritin, elevated white blood cell count, and lower lymphocyte count than non-severe cases with a significant difference between the two groups. The areas under the curve (AUC) for C-reactive protein, procalcitonin and D-dimer were 0.886, 0.708, and 0.736 respectively. The optimal thresholds predictive of severity were 105 mg/l for C-reactive protein, 0.13 ng/ml for procalcitonin, 7420/mu l for white blood cell count, and 0.55 mg/l for D-dimer. Conclusion: Comparison of the proportion of clinical, biological and radiological data between severe and nonsevere cases of COVID-19, as well as identification of biomarkers for the development of severe form in the present study, will allow optimal streamlining of management with rapid triage of patients.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Clinical Characteristics and Remedy Profiles of Patients with COVID-19: A Retrospective Cohort Study
    Jethani, Bipin
    Gupta, Meeta
    Wadhwani, Parul
    Thomas, Rekha
    Balakrishnan, Thankaraj
    Mathew, George
    Mathur, Mohit
    Rao, Bachha Pompi
    Shukla, Dhananjay
    Khullar, Aashima
    Khera, Meghna
    Sharma, Himani
    Kumar, Ravinder
    Kumar, Sudeep
    Jaggi, Sayami
    Sinha, Robin
    Rawal, Kamal
    Kapoor, Anu
    Manchanda, Raj Kumar
    HOMEOPATHY, 2021, 110 (02) : 86 - 93
  • [2] Clinical Characteristics of Hospitalized Patients With COVID-19: A Retrospective Cohort Study in Pakistan
    Aujla, Usman I.
    Syed, Imran A.
    Khalid, Abdullah
    Hanif, Muhammad Farooq
    Malik, Ahmad K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [3] Outcomes and Clinical Characteristics of COVID-19 in Patients with Tuberculosis: A Retrospective Matched Cohort Study
    Hartnady, Zachary
    Krehbiel, Benjamin
    Stenzel, Ashley
    Tierney, David
    INFECTIOUS DISEASE REPORTS, 2023, 15 (02) : 204 - 209
  • [4] Clinical Characteristics and Outcomes of COVID-19 in Pediatric Cancer Patients: A Retrospective Cohort Study
    Badiepour, Sara
    Kamfar, Sharareh
    Alavi, Samin
    Armin, Shahnaz
    Taherian, Reza
    ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, 2025, 13 (02):
  • [5] Epidemiological and Clinical Characteristics of COVID-19 Patients in Northern Ethiopia: A Retrospective Cohort Study
    Abebe, Haftom Temesgen
    Ashebir, Mengistu Mitiku
    Ebrahim, Mohamedawel Mohamedniguss
    Zelelow, Yibrah Berhe
    Bezabih, Afework Mulugeta
    Tefere, Getachew Redae
    Teklehaimanot, Berhane Fseha
    Hintsa, Solomon
    Welderufael, Abadi Leul
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 3579 - 3588
  • [6] Clinical characteristics of COVID-19 patients with asthma in Wuhan, China: a retrospective cohort study
    Jin, Meng
    Chen, Can
    Huang, Jinyu
    Zhang, Fengqin
    Dong, Tianyi
    Zhang, Ming
    Yue, Huihui
    Liu, Kui
    Li, Guangcai
    Hu, Ke
    Zhang, Huilan
    JOURNAL OF ASTHMA, 2022, 59 (02) : 230 - 238
  • [7] Clinical Characteristics and Durations of Hospitalized Patients with COVID-19 in Beijing: A Retrospective Cohort Study
    Zhao, Wen
    Zha, Xiangyi
    Wang, Ning
    Li, Dongzeng
    Li, Aixin
    Yu, Shikai
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2021, 6 (01) : 33 - 44
  • [8] Clinical Characteristics and Risk Factors for Mortality in COVID-19 Patients: A Retrospective Cohort Study
    Khajoei, Rahimeh
    Heydarpour, Nabiollah
    Sadeghi, Reza
    Balvardi, Mohadeseh
    Jafari, Hamid
    Shokohian, Sajad
    Rahmani, Farzad
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (05) : LC9 - LC14
  • [9] Retrospective analysis of clinical characteristics of 405 patients with COVID-19
    Zhan, Ting
    Liu, Meng
    Tang, Yalin
    Han, Zheng
    Cheng, Xueting
    Deng, Junsheng
    Chen, Xiaoli
    Tian, Xia
    Huang, Xiaodong
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (08)
  • [10] Epidemiology and clinical characteristics of headache among COVID-19 patients in Lebanon: a retrospective cohort study
    Safawi, Nour
    Hasbini, Jida
    Khodor, Hawaa
    Atrouni, Salim
    Berjaoui, Christin
    ElJarkass, Hania
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2024, 60 (01):